Literature DB >> 9860892

Estimation of toxicity of chemical mixtures through modeling of chemical interactions.

M M Mumtaz1, C T De Rosa, J Groten, V J Feron, H Hansen, P R Durkin.   

Abstract

The Agency for Toxic Substances and Disease Registry (ATSDR), in collaboration with the Dutch Organization for Applied Scientific Research (TNO) Nutrition and Food Research Institute, is conducting studies to evaluate the role of chemical interactions in the expression of toxicity from low-level exposure to combinations of chemicals. The goal of this collaborative effort is to use a weight-of-evidence (WOE) approach to estimate joint toxicity of some simple chemical mixtures and to compare the estimations with test results from animal toxicity studies. The WOE approach uses individual chemical dose-response assessments and algorithms that incorporate various assumptions regarding potential chemical interactions. Qualitative evaluations were prepared for binary combinations of chemicals for the effect of butyl hydroxyanisole on di(2-ethylhexyl)phthalate, the effect of stannous chloride on Cd chloride (CdCl2), and the effect of CdCl2 on loperamide. Analyses of these evaluations and their comparison with the conclusions of laboratory animal experiments indicate that the WOE approach can be used to estimate qualitatively the joint toxicity of such simple mixtures. To further test the utility of the WOE approach, qualitative and semiquantitative evaluations were prepared for two chemical mixtures--one with similarly acting halogenated aliphatics (trichloroethylene, tetrachloroethylene, hexachloro-1,3-butadiene[HCBD], and 1,1,2-trichloro-3,3,3-trifluoropropene [TCTFP]) and the other with dissimilarly acting nephrotoxic components (mercuric chloride, lysinolalanine, D-limonene, and HCBD). These two sets of data were used to estimate the overall toxicities of the mixtures using the WOE algorithm for the mixture. The comparison of the results of the estimated toxicity with experimentally determined toxicity of the mixture of similarly acting nephrotoxicants demonstrated that the WOE approach correctly adjusted for the observed interactions in experimental animal studies. However, this was not true for the mixture of dissimilarly acting nephrotoxicants. This could be attributed to the fact that WOE evaluations are based on dose additivity that postulates that all chemicals in a given mixture act in the same way--by the same mechanism--and differ only in their potencies. In these cases the WOE approach evaluations, based on consideration of common mechanisms for simple chemical mixtures, can lead to better estimates of joint toxicity of chemical mixtures than the default assumption of dose additivity. The results also show that the WOE evaluations should be target-organ specific because none of the models tested could approximate the observed responses in organs other than the target organs in the laboratory animal studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860892      PMCID: PMC1533446          DOI: 10.1289/ehp.98106s61353

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  10 in total

1.  Reference dose (RfD): description and use in health risk assessments.

Authors:  D G Barnes; M Dourson
Journal:  Regul Toxicol Pharmacol       Date:  1988-12       Impact factor: 3.271

Review 2.  A weight-of-evidence approach for assessing interactions in chemical mixtures.

Authors:  M M Mumtaz; P R Durkin
Journal:  Toxicol Ind Health       Date:  1992 Nov-Dec       Impact factor: 2.273

3.  Chemical mixtures released from hazardous waste sites: implications for health risk assessment.

Authors:  B L Johnson; C T DeRosa
Journal:  Toxicology       Date:  1995-12-28       Impact factor: 4.221

4.  Changes in the nasal epithelium of rats exposed by inhalation to mixtures of formaldehyde, acetaldehyde, and acrolein.

Authors:  F R Cassee; J P Groten; V J Feron
Journal:  Fundam Appl Toxicol       Date:  1996-02

5.  Toxicity of mixtures of nephrotoxicants with similar or dissimilar mode of action.

Authors:  D Jonker; R A Woutersen; V J Feron
Journal:  Food Chem Toxicol       Date:  1996 Nov-Dec       Impact factor: 6.023

6.  Subacute toxicity of a mixture of nine chemicals in rats: detecting interactive effects with a fractionated two-level factorial design.

Authors:  J P Groten; E D Schoen; P J van Bladeren; C F Kuper; J A van Zorge; V J Feron
Journal:  Fundam Appl Toxicol       Date:  1997-03

7.  Comparative effects of BHA and ascorbic acid on the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats.

Authors:  M Q Hassan; H Mohammadpour; S J Hermansky; W J Murray; S J Stohs
Journal:  Gen Pharmacol       Date:  1987

8.  Nonadditive developmental toxicity in mixtures of trichloroethylene, Di(2-ethylhexyl) phthalate, and heptachlor in a 5 x 5 x 5 design.

Authors:  M G Narotsky; E A Weller; V M Chinchilli; R J Kavlock
Journal:  Fundam Appl Toxicol       Date:  1995-09

9.  Endrin-induced histopathological changes and lipid peroxidation in livers and kidneys of rats, mice, guinea pigs and hamsters.

Authors:  M Q Hassan; I T Numan; N al-Nasiri; S J Stohs
Journal:  Toxicol Pathol       Date:  1991       Impact factor: 1.902

10.  Subacute (4-wk) oral toxicity of a combination of four nephrotoxins in rats: comparison with the toxicity of the individual compounds.

Authors:  D Jonker; R A Woutersen; P J van Bladeren; H P Til; V J Feron
Journal:  Food Chem Toxicol       Date:  1993-02       Impact factor: 6.023

  10 in total
  2 in total

1.  Application of physiologically based pharmacokinetic models in chemical risk assessment.

Authors:  Moiz Mumtaz; Jeffrey Fisher; Benjamin Blount; Patricia Ruiz
Journal:  J Toxicol       Date:  2012-03-19

2.  In silico toxicology: simulating interaction thresholds for human exposure to mixtures of trichloroethylene, tetrachloroethylene, and 1,1,1-trichloroethane.

Authors:  Ivan D Dobrev; Melvin E Andersen; Raymond S H Yang
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.